161 related articles for article (PubMed ID: 19287191)
1. Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells.
Yoo HJ; Yun BR; Kwon JH; Ahn HS; Seol MA; Lee MJ; Yu GR; Yu HC; Hong B; Choi K; Kim DG
Exp Mol Med; 2009 Feb; 41(2):102-15. PubMed ID: 19287191
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma.
Seol MA; Chu IS; Lee MJ; Yu GR; Cui XD; Cho BH; Ahn EK; Leem SH; Kim IH; Kim DG
BMC Cancer; 2011 Feb; 11():78. PubMed ID: 21333016
[TBL] [Abstract][Full Text] [Related]
3. ANXA8 down-regulation by EGF-FOXO4 signaling is involved in cell scattering and tumor metastasis of cholangiocarcinoma.
Lee MJ; Yu GR; Yoo HJ; Kim JH; Yoon BI; Choi YK; Kim DG
Gastroenterology; 2009 Sep; 137(3):1138-50, 1150.e1-9. PubMed ID: 19376120
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
Kim JH; Liu L; Lee SO; Kim YT; You KR; Kim DG
Cancer Res; 2005 Jul; 65(14):6312-20. PubMed ID: 16024633
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of chromosomal aberrations in human cholangiocarcinoma cell lines by cross-species color banding.
Kim DG; Park SY; You KR; Lee GB; Kim H; Moon WS; Chun YH; Park SH
Genes Chromosomes Cancer; 2001 Jan; 30(1):48-56. PubMed ID: 11107175
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the fragile histidine triad gene in intrahepatic cholangiocarcinoma.
Koch E; Fiedler W; Tannapfel A; Ballhausen WG
Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):907-13. PubMed ID: 12867802
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of ATF3 repression of epithelial-mesenchymal transition and suppression of cell viability in cholangiocarcinoma via p53 signal pathway.
You Z; Xu J; Li B; Ye H; Chen L; Liu Y; Xiong X
J Cell Mol Med; 2019 Mar; 23(3):2184-2193. PubMed ID: 30648816
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocellular and cholangiocarcinoma.
Aishima S; Kuroda Y; Asayama Y; Taguchi K; Nishihara Y; Taketomi A; Tsuneyoshi M
Hum Pathol; 2006 Mar; 37(3):283-91. PubMed ID: 16613323
[TBL] [Abstract][Full Text] [Related]
9. Regulators of apoptosis in cholangiocarcinoma.
Jhala NC; Vickers SM; Argani P; McDonald JM
Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
[TBL] [Abstract][Full Text] [Related]
10. Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma.
Furubo S; Harada K; Shimonishi T; Katayanagi K; Tsui W; Nakanuma Y
Histopathology; 1999 Sep; 35(3):230-40. PubMed ID: 10469215
[TBL] [Abstract][Full Text] [Related]
11. p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components.
Lien HC; Lin CW; Mao TL; Kuo SH; Hsiao CH; Huang CS
J Pathol; 2004 Oct; 204(2):131-9. PubMed ID: 15376261
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
Foja S; Goldberg M; Schagdarsurengin U; Dammann R; Tannapfel A; Ballhausen WG
Liver Int; 2005 Dec; 25(6):1202-8. PubMed ID: 16343073
[TBL] [Abstract][Full Text] [Related]
13. CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis.
Miyata T; Yamashita YI; Yoshizumi T; Shiraishi M; Ohta M; Eguchi S; Aishima S; Fujioka H; Baba H
Cancer Sci; 2019 Oct; 110(10):3197-3203. PubMed ID: 31361379
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of sarcomatous cholangiocarcinoma of the liver.
Shimada M; Takenaka K; Rikimaru T; Hamatsu T; Yamashita Y; Kajiyama K; Taguchi K; Shirabe K; Sugimachi K
Hepatogastroenterology; 2000; 47(34):956-61. PubMed ID: 11020857
[TBL] [Abstract][Full Text] [Related]
15. The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.
Romero I; Martinez M; Garrido C; Collado A; Algarra I; Garrido F; Garcia-Lora AM
J Pathol; 2012 Jul; 227(3):367-79. PubMed ID: 22451343
[TBL] [Abstract][Full Text] [Related]
16. A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition.
Seok JY; Na DC; Woo HG; Roncalli M; Kwon SM; Yoo JE; Ahn EY; Kim GI; Choi JS; Kim YB; Park YN
Hepatology; 2012 Jun; 55(6):1776-86. PubMed ID: 22234953
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway.
Dong G; Loukinova E; Chen Z; Gangi L; Chanturita TI; Liu ET; Van Waes C
Cancer Res; 2001 Jun; 61(12):4797-808. PubMed ID: 11406555
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Assessment of the Expression of Biliary Transportation Proteins MRP2 and MRP3 in Hepatocellular Carcinoma and in Cholangiocarcinoma.
Cirqueira CS; Felipe-Silva AS; Wakamatsu A; Marins LV; Rocha EC; de Mello ES; Alves VAF
Pathol Oncol Res; 2019 Oct; 25(4):1363-1371. PubMed ID: 29464551
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
[TBL] [Abstract][Full Text] [Related]
20. Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study.
Cong WM; Bakker A; Swalsky PA; Raja S; Woods J; Thomas S; Demetris AJ; Finkelstein SD
J Cancer Res Clin Oncol; 2001; 127(3):187-92. PubMed ID: 11260864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
